Keyphrases
Body Mass Index
100%
Lung Squamous Cell Carcinoma
100%
Immune Cells
100%
Pretreatment Effect
100%
Immune Checkpoint Inhibitor Therapy
100%
High Body Mass Index
75%
Immune Checkpoint Inhibitors
50%
Low Body Mass Index
50%
Rizhao
50%
Confidence Interval
25%
Progression-free Survival
25%
Median Progression-free Survival
25%
Chemotherapy
25%
Adjusted Hazard Ratio
25%
Newly Diagnosed Patients
25%
Better Prognosis
25%
Shandong
25%
Different Pretreatment
25%
Medicine and Dentistry
Body Mass Index
100%
Immunocompetent Cell
100%
Squamous Cell Lung Carcinoma
100%
Immune Checkpoint Inhibitor
100%
Hazard Ratio
11%
Progression Free Survival
11%
Survival Time
11%
Immunology and Microbiology
Immunocompetent Cell
100%
Immunity
100%
Squamous Cell
100%
Body Mass
100%
Survival Time
12%
Progression Free Survival
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antiserum
100%
Immune Checkpoint Inhibitor
100%
Squamous Cell Lung Carcinoma
100%
Progression Free Survival
25%
Chemotherapy
25%
Survival Time
25%